More experiments are needed to get better insights into the relationships between ErbB signalling and intracellular trafficking in HCC, in order to improve, ultimately, the therapeutic strategies based on targeting the ErbB receptor family. The gene discussed is EGFR; the disease is hepatocellular carcinoma.